Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants
Top Cited Papers
- 14 March 2001
- Vol. 19 (17-19) , 2534-2541
- https://doi.org/10.1016/s0264-410x(00)00553-3
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Crystal structure of a non‐toxic mutant of heat‐labile enterotoxin, which is a potent mucosal adjuvantProtein Science, 1997
- The adjuvant effect of a non‐toxic mutant of heat‐labile enterotoxin of Escherichia coli for the induction of measles virus‐specific CTL responses after intranasal co‐immunization with a synthetic peptideImmunology, 1996
- Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile EnterotoxinThe Journal of Infectious Diseases, 1996
- ARF: a key regulatory switch in membrane traffic and organelle structureCurrent Opinion in Cell Biology, 1994
- Refined Structure of Escherichia coli Heat-labile Enterotoxin, a Close Relative of Cholera ToxinJournal of Molecular Biology, 1993
- Comparison of the B-pentamers of heat-labile enterotoxin and verotoxin-1: two structures with remarkable similarity and dissimilarityBiochemistry, 1993
- Cholera toxin and cholera B subunit as oral—mucosal adjuvant and antigen vector systemsVaccine, 1993
- Glutamic acid‐112 of the A subunit of heat‐labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP‐ribosyltransferase activityFEBS Letters, 1991
- Intestinal Electrolyte Transport and Diarrheal DiseaseNew England Journal of Medicine, 1989
- Origin of the Enzymatically Active AI Fragment of Cholera ToxinThe Journal of Infectious Diseases, 1979